Mivacurium infusion requirement and spontaneous recovery of neuromuscular transmission in children anaesthetized with nitrous oxide and fentanyl, halothane, isoflurane or sevoflurane

Paediatric Anaesthesia

Volumn 12, Issue 6, 2002, Pages 511-518

  Woloszczuk Gebicka, B ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

Anaesthetics, halothane, isoflurane, sevoflurane; Continuous infusion; Fentanyl; Recovery; Relaxants: mivacurium

Indexed keywords

DIAZEPAM; FENTANYL; HALOTHANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; MIDAZOLAM; MIVACURIUM; NITROUS OXIDE; OXYGEN; SEVOFLURANE;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ELECTROMYOGRAPHY; HUMAN; INHALATION ANESTHESIA; MUSCLE RELAXATION; NEUROMUSCULAR TRANSMISSION; PEDIATRIC ANESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ULNAR NERVE;

ANESTHESIA, INHALATION; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FENTANYL; HALOTHANE; HUMANS; INFUSIONS, INTRAVENOUS; ISOFLURANE; ISOQUINOLINES; METHYL ETHERS; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR NONDEPOLARIZING AGENTS; NITROUS OXIDE; SYNAPTIC TRANSMISSION;

EID: 0036360705     PISSN: 11555645     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2002.00901.x     Document Type: Article

References (46)

1. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U): A short acting nondepolarizing ester neuromuscular blocking drug
2. In vitro metabolism of mivacurium chloride (BW B1090U) and succinylcholine
3. Comparison of mivacurium administered by bolus and infusion
4. Comparison of neuromus-cular block induced by mivacurium, suxamethonium or atracurium during nitrous oxide-fentanyl anaesthesia
5. A comparison of mivacurium dosage requirements during isoflurane and desflurane anesthesia
6. Clinical pharmacology of mivacurium chloride (BW B1090U) infusion: Comparison with vecuronium and atracurium
7. Mivacurium induced neuromuscular blockade following single bolus doses and with continuous infusion during either balanced or enflurane anesthesia
8. Neuromuscular and cardiovascular effects of mivacurium in children
9. Recovery from mivacurium after long procedures
10. Mivacurium. A review of its pharmacology and therapeutic potential in general anesthesia
11. Clinical pharmacology of mivacurium chloride (BW B1090U) in children during nitrous oxide-halothane and nitrous oxide-narcotic anesthesia
12. Mivacurium infusion requirements in pediatric surgical patients during nitrous oxide-halothane and during nitrous oxide-narcotic anesthesia
13. Neuromuscular and cardiovascular effects of mivacurium chloride (BW B1090U) during nitrous oxide-fentanyl-thiopentone and nitrous oxide-halothane anaesthesia
14. Effects of halothane, enflurane and isoflurane on pharmacodynamics of mivacuri-um in children
15. Time course of potentiation of mivacurium by halothane and isoflurane in children
16. The effect of halothane on mivacurium infusion in adult surgical patients
17. Mivacurium infusion during nitrous oxide-isoflurane anaesthesia: A comparison with nitrous oxide-opioid anesthesia
18. Quantifying the effect of isoflurane on mivacurium infusion requirements in adult surgical patients
19. Decreased mivacurium requirement and delayed neuromuscular recovery during sevoflurane anesthesia in children and adults
20. Potency and time-course of mivacurium during sevoflurane, isoflurane and intravenous anaesthesia
21. Augmentation of neuromuscular blocking effect of mivacurium by desflurane, sevoflurane, isoflurane in comparison with TIVA
22. Mivacurium induced blockade during sevoflurane and halothane anaesthesia in children
23. Residual block after mivacurium with or without edrophonium reversal in adults and children
24. Recovery characteristics after early administration of anticholinsterases during intense mivacurium induced neuromuscular block
25. Dose-response for neostigmine and edrophonium as antagonists of mivacurium in adults and children
26. Antagonism of mivacurium block with edrophonium from various degrees of spontaneous recovery
27. The relationship between age and halothane requirement in man
28. The minimum anesthetic concentration of isoflurane in children
29. Minimum alveolar concentration of sevo-flurane in children
30. A comparison of mivacurium requirement between young and elderly adult patients
31. Mivacurium chloride administration by infusion
32. The nature of spontaneous recovery from mivacurium-induced neuromuscular block
33. Pharmacodynamics of mivacurium in children, using a computer-controlled infusion
34. Mivacurium chloride in infants and children
35. Age-related variability in the effects of mivacurium in paediatric surgical patients
36. Does age or pseudocholinesterase activity predict mivacurium infusion rate in children?
37. Continuous infusion of mivacurium in children
38. A comparison between mivacurium and suxamethonium in children
39. Prolonged neuromuscular blockade caused by mivacurium in a pediatric patient
40. Prolonged mivacurium neuromuscular block in children
41. Spontaneous versus edrophonium-induced recovery from paralysis with mivacurium
42. Neuromuscular effects of mivacurium in children with burn injury
43. Pharmacodynamics and safety of mivacurium in infants and children under halothane-nitrous oxide anesthesia
44. Recovery of mivacurium block with or without anticholinesterases following administration by continuous infusion
45. Effects of halothane and sevoflurane on reversal of neuromuscular blockade induced by vecuronium in man
46. Factors affecting neostigmine reversal of vecuronium block during sevoflurane anaesthesia